GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Aveo Healthcare Ltd (ASX:AEH) » Definitions » EBITDA

Aveo Healthcare (ASX:AEH) EBITDA : A$-2.64 Mil (TTM As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Aveo Healthcare EBITDA?

Aveo Healthcare's EBITDA for the six months ended in Dec. 2013 was A$-4.78 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2013 was A$-2.64 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Aveo Healthcare's EBITDA per Share for the six months ended in Dec. 2013 was A$-0.06. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2013 was A$-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Aveo Healthcare EBITDA Historical Data

The historical data trend for Aveo Healthcare's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveo Healthcare EBITDA Chart

Aveo Healthcare Annual Data
Trend Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.96 26.66 55.47 -62.35 -3.40

Aveo Healthcare Semi-Annual Data
Jun04 Dec04 Jun05 Dec05 Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 -65.19 -5.53 2.14 -4.78

Competitive Comparison of Aveo Healthcare's EBITDA

For the Real Estate Services subindustry, Aveo Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aveo Healthcare's EV-to-EBITDA Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Aveo Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aveo Healthcare's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Aveo Healthcare's EBITDA for the fiscal year that ended in Jun. 2013 is calculated as

Aveo Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jun. 2013, Aveo Healthcare's EBITDA was A$-3.40 Mil.

Aveo Healthcare's EBITDA for the quarter that ended in Dec. 2013 is calculated as

Aveo Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2013, Aveo Healthcare's EBITDA was A$-4.78 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2013 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Aveo Healthcare  (ASX:AEH) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Aveo Healthcare EBITDA Related Terms

Thank you for viewing the detailed overview of Aveo Healthcare's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveo Healthcare (ASX:AEH) Business Description

Traded in Other Exchanges
N/A
Address
Aveo Healthcare Ltd provides retirement communities in South-East Queensland. The Company's healthcare's portfolio comprises five retirement villages, located in Albany Creet, Clayfield, Cleveland, Durack and Taringa.

Aveo Healthcare (ASX:AEH) Headlines

From GuruFocus

Aegon Bank has set up an additional Covered Bond Program

By Business Wire Business Wire 05-10-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 07-05-2022

Maarten Edixhoven to leave Aegon the Netherlands

By Business Wire Business Wire 05-11-2021

Aegon Bank publishes its 2020 annual report

By Business Wire Business Wire 04-30-2021

Allegra van H�vell-Patrizi appointed CEO of Aegon the Netherlands

By Business Wire Business Wire 06-15-2021

Aegon NV Stock Shows Every Sign Of Being Fairly Valued

By GF Value GF Value 04-23-2021

Aegon Asset Management closes first deal in ESG-centric venture

By PRNewswire PRNewswire 06-15-2022